219 related articles for article (PubMed ID: 38275032)
1. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Implications.
Liu L; Kaur GI; Kumar A; Kanwal A; Singh SP
Cardiovasc Hematol Agents Med Chem; 2024 Jan; ():. PubMed ID: 38275032
[TBL] [Abstract][Full Text] [Related]
2. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
[TBL] [Abstract][Full Text] [Related]
3. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD).
Hemmati M; Kashanipoor S; Mazaheri P; Alibabaei F; Babaeizad A; Asli S; Mohammadi S; Gorgin AH; Ghods K; Yousefi B; Eslami M
Life Sci; 2023 Sep; 329():121947. PubMed ID: 37463653
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.
Usman I; Anwar A; Shukla S; Pathak P
Cardiovasc Hematol Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38879769
[TBL] [Abstract][Full Text] [Related]
5. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota.
Alhajri N; Khursheed R; Ali MT; Abu Izneid T; Al-Kabbani O; Al-Haidar MB; Al-Hemeiri F; Alhashmi M; Pottoo FH
Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683334
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
Trøseid M; Andersen GØ; Broch K; Hov JR
EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
[TBL] [Abstract][Full Text] [Related]
8. [Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].
Li Y; Cui M; Sun J; Wei Q; Liu M; Zhang J; Qi H; Zhao L; Fang H; Chen Z; Lü S
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3745-3756. PubMed ID: 34841781
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus.
Sánchez-Quintero MJ; Delgado J; Medina-Vera D; Becerra-Muñoz VM; Queipo-Ortuño MI; Estévez M; Plaza-Andrades I; Rodríguez-Capitán J; Sánchez PL; Crespo-Leiro MG; Jiménez-Navarro MF; Pavón-Morón FJ
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364913
[TBL] [Abstract][Full Text] [Related]
10. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Microbiome in Heart Failure.
Kitai T; Kirsop J; Tang WH
Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
[TBL] [Abstract][Full Text] [Related]
13. Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack.
Yin J; Liao SX; He Y; Wang S; Xia GH; Liu FT; Zhu JJ; You C; Chen Q; Zhou L; Pan SY; Zhou HW
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26597155
[TBL] [Abstract][Full Text] [Related]
14. Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD).
Yoo JY; Sniffen S; McGill Percy KC; Pallaval VB; Chidipi B
Microorganisms; 2022 Jan; 10(1):. PubMed ID: 35056557
[TBL] [Abstract][Full Text] [Related]
15. The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease.
El Hage R; Al-Arawe N; Hinterseher I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768722
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis.
Manolis AA; Manolis TA; Melita H; Manolis AS
Curr Med Chem; 2022; 29(23):4050-4077. PubMed ID: 34961453
[TBL] [Abstract][Full Text] [Related]
17. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure.
Anderson KM; Ferranti EP; Alagha EC; Mykityshyn E; French CE; Reilly CM
Heart Fail Rev; 2022 Nov; 27(6):2223-2249. PubMed ID: 35726110
[TBL] [Abstract][Full Text] [Related]
18. Role of gut microbiota in cardiovascular diseases.
Novakovic M; Rout A; Kingsley T; Kirchoff R; Singh A; Verma V; Kant R; Chaudhary R
World J Cardiol; 2020 Apr; 12(4):110-122. PubMed ID: 32431782
[TBL] [Abstract][Full Text] [Related]
19. The interplay between microbial metabolites and macrophages in cardiovascular diseases: A comprehensive review.
Yang Y; Karampoor S; Mirzaei R; Borozdkin L; Zhu P
Int Immunopharmacol; 2023 Aug; 121():110546. PubMed ID: 37364331
[TBL] [Abstract][Full Text] [Related]
20. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease.
Zhu J; Lyu J; Zhao R; Liu G; Wang S
Front Microbiol; 2023; 14():1272479. PubMed ID: 37822750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]